Your Health. Your Family. Your Choice.
Administered by: Private Purchased by: Private
Life Threatening? No
Write-up: This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative and from a contactable nurse. A 17-year-old female patient of an unspecified ethnicity received, on 06Aug2015 11:30, TRUMENBA (Lot# J29203, expiration date Jun2016), intramuscular at 0.5 ml single dose in the left deltoid. Relevant medical history and concomitant medications were unknown. On an unspecified date, in Aug2015, the patient experienced itchy at the site of injection, big rash red, sore and itchy. Treatment received included BENADRYL, ALLEGRA and ZYRTEC. The patient did not recover from the event, rash erythematous; while clinical outcome of the other events was unknown. There was a reasonable possibility that the events was related to TRUMENBA. Follow up (01Sep2015): 06 Aug 2015 New information obtained from a contactable nurse includes: lot# and expiration date, route of administration, dose, anatomical location and start date (updated) for TRUMENBA; patient''s date of birth. Follow-up attempts completed. No further information expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166